Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of mortality and morbidity globally. According to the Global Burden of Disease studies, COPD is among the top three causes of death worldwide, imposing significant healthcare and socioeconomic burdens. Its insidious onset and chronic progression complicate early diagnosis and therapeutic intervention. COPD is fundamentally characterized […]
Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of mortality and morbidity globally. According to the Global Burden of Disease studies, COPD is among the top three causes
Antigen-specific tolerance is a fundamental aspect of immune regulation, critical in the context of both autoimmune disease and cancer. In vitro assays using human immune cells provide a mechanistic platform
Download the full article (PDF) MarinBio Blog Advances in Gene Therapy for Ultra-Rare Genetic Disorders Introduction Ultra-rare hereditary genetic disorders represent some of the most challenging conditions in medicine. Affecting
Download the full article (PDF) MarinBio BLOG The CAR-Treg Rebellion Chimeric Antigen Receptor (CAR)-engineered regulatory T cells (CAR-Tregs) represent a distinct and rapidly emerging frontier in cellular immunotherapy, offering
Introduction Cancer treatment has undergone a dramatic transformation in recent years, moving from broad cytotoxic chemotherapies toward molecularly precise strategies tailored to specific genetic, epigenetic, and proteomic vulnerabilities. The
G Protein Coupled Receptors (GPCRs) represent a vast and diverse family of membrane proteins that are central to the regulation of human immune cell function. These receptors mediate responses
Introduction Autoimmune diseases constitute a complex group of disorders in which immune system dysregulation leads to chronic inflammation and tissue damage. Among these diseases, rheumatoid arthritis (RA), inflammatory bowel disease
Flow cytometry stands at the forefront of cancer diagnostics and therapeutics, transforming oncology practice through its capacity to dissect cellular and molecular complexity. By enabling the simultaneous measurement of
CAR T-cell therapy represents a significant shift in the treatment landscape for cancer, particularly in hematologic malignancies. Unlike traditional immunotherapies, Chimeric Antigen Receptor (CAR) T-cells are genetically engineered T lymphocytes
The mixed lymphocyte reaction (MLR) is a basic immunological assay used to study T cell responses to allogeneic antigens (from different individuals). By co-culturing peripheral blood mononuclear cells (PBMCs)
